Galectin Therapeutics (GALT) Falls: Stock Goes Down 11.3% - Tale of the Tape - Galectin Therapeutics (NASDAQ:GALT)

Galectin Therapeutics, Inc. GALT saw a big move last session, as the company's shares fell by over 11% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This stock, trading at a volatile range of $14.51–$17.05 in the past one-month time frame, showed a sharp decline yesterday at $13.58.

This drug development company has seen a flat track record when it comes to current year estimate revisions with no change over the past few weeks. The consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.

GALT currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.0%.

Some better-ranked stocks in the Med-Drugs sector include Sucampo Pharmaceuticals, Inc. SCMP, Lannett Company, Inc. LCI and Questcore Pharmaceuticals, Inc. QCOR. All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

GALECTIN THERAP GALT: Get Free Report

To read this article on Zacks.com click here.

Market News and Data brought to you by Benzinga APIs